SSH GUIDELINES
SSH guidelines policy update 01.05.2021
Please click on the respective title to see the guidelines
1) Thrombosis and hemostasis
- Recommendations for the use of andexanet alfa in the management of bleeding in patients on oral factor Xa inhibitors in Switzerland (This document is currently being updated)
- „How to diagnose and treat acquired hemophilia“ (Last update: 8.4.2025)
- Recommendations on the use of anticoagulants for the treatment of patients with heparin-induced thrombocytopenia in Switzerland (This document is currently being updated)
- Management of bleeding events and invasive procedures in patients with haemophilia A without inhibitors treated with emicizumab (This document is currently being updated)
2) Malignant Hematology
- Expert recommendation from the Swiss Amyloidosis Network (SAN) for systemic AL-amyloidosis | Swiss Medical Weekly
- View of Updated recommendations for the treatment of light-chain amyloidosis from the Swiss Amyloidosis Network
3) Nuclear accidents
Newsletter „Netzwerk Strahlenunfall Schweiz“
- Newsletter 01-25_DE
- Newsletter 01-25_EN
- Newsletter 02-24_DE
- Newsletter 02-24_EN
- Newsletter 01-24_DE
- Newsletter 01-24_EN
- Newsletter 01-23_DE
- Newsletter 01-23_EN